Group 1 - The company has not distributed cash dividends or bonus shares during the reporting period [3] - The company has not changed its controlling shareholder or actual controller during the reporting period [5][6] - The company plans to hold its first extraordinary general meeting of 2025 on September 16, 2025 [18] Group 2 - The company has approved the appointment of Yunitai Zhenqing Accounting Firm as its auditor for the 2025 fiscal year [17][34] - The decision to change the accounting firm was made after considering the company's business development and audit needs [44] - The new auditor has a history of providing audit services to listed companies and has been recognized for its professional capabilities [36][37] Group 3 - The company has revised its articles of association and related governance documents to enhance its governance structure [12][28] - The revisions include the elimination of the supervisory board, with its responsibilities transferred to the audit committee of the board [12][14] - The revised articles and governance documents will be submitted for approval at the upcoming extraordinary general meeting [16][29]

Fundraising Overview - The company raised a total of RMB 595.95 million through the issuance of 27.4 million shares at a price of RMB 21.75 per share, with a net amount of RMB 560.19 million after deducting issuance costs [1] - As of June 30, 2025, the company has utilized RMB 585.12 million of the raised funds, leaving a balance of RMB 5.13 million [2] Fund Management and Usage - The company has established a fundraising management system in compliance with relevant laws and regulations, ensuring that funds are stored in dedicated accounts and used specifically for designated projects [3] - A tripartite supervision agreement was signed with several banks to oversee the management and usage of the raised funds [4][5] - The company has not used idle funds for temporary working capital or cash management during the reporting period [7][8] Investment Projects - The company has made adjustments to some fundraising investment projects to improve efficiency, which were disclosed in a timely manner [5] - As of June 30, 2025, there were no pre-investments or replacements of funds for investment projects [6][9] Profit Distribution - The company proposed a cash dividend of RMB 1.50 per 10 shares, totaling approximately RMB 21.71 million, which represents 68.89% of the company's net profit for the first half of 2025 [15][18] Overseas Investment - The company plans to invest up to USD 20.5 million in building a production base in Vietnam to enhance its international competitiveness and optimize its global strategic layout [24][28] - The investment aims to improve supply chain resilience and reduce tariff costs, responding to changes in the trade environment [29][30] Audit Firm Appointment - The company intends to reappoint Rongcheng Certified Public Accountants as its auditor for the year 2025, pending approval from the upcoming shareholders' meeting [33][46]

Core Points - The company is holding its first extraordinary general meeting of shareholders in 2025, scheduled for September 15, 2025, at 10:00 AM in Beijing [5][6]. - The meeting will address several key proposals, including the reappointment of the accounting firm for the 2025 financial year and amendments to the company's articles of association [7][14]. Meeting Procedures - Attendees must arrive 30 minutes early for registration and identification verification [1]. - Only shareholders, their proxies, and invited guests are allowed to enter the meeting venue [1][2]. - Shareholders have the right to speak, ask questions, and vote, but must register their intent to speak beforehand [2][3]. - Voting will be conducted through a combination of on-site and online methods, with each share carrying one vote [3][5]. Agenda Items - The agenda includes the reappointment of Tianjian Accounting Firm as the auditor for the 2025 financial year, with a proposed fee of 300,000 yuan, unchanged from the previous year [8][11]. - A proposal to change the registered address of the company and to abolish the supervisory board is also on the agenda [14][15]. - Amendments to the company's articles of association will be discussed to align with recent legal updates and improve governance [14][15]. Voting and Decision-Making - The meeting will utilize a named voting method, where shareholders can choose to agree, disagree, or abstain from each proposal [3]. - The results of the voting will be announced after the meeting, combining both on-site and online votes [3][5]. - The proposals require a two-thirds majority from the voting shareholders to pass [16].

证券代码：688351 证券简称：微电生理 公告编号：2025-020 上海微创电生理医疗科技股份有限公司 关于续聘会计师事务所公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 拟聘任会计师事务所名称：立信会计师事务所（特殊普通合伙） 上海微创电生理医疗科技股份有限公司（以下简称"公司"）于 2025 年 8 月 审议通过了《关于续聘 2025 年度会计师事务所的议案》，公司拟续聘立信会计师 （以下简称"立信"）为公司 2025 年度审计机构，本事项 事务所（特殊普通合伙） 尚需提交公司股东大会审议。现将相关事项公告如下： 一、拟续聘会计师事务所的基本情况 （一）机构信息 立信会计师事务所（特殊普通合伙）由我国会计泰斗潘序伦博士于 1927 年 在上海创建，1986 年复办，2010 年成为全国首家完成改制的特殊普通合伙制会 计师事务所，注册地址为上海市，首席合伙人为朱建弟先生。立信是国际会计网 络 BDO 的成员所，长期从事证券服务业务，新证券法实施前具有证券、期货业 务许可证，具有 H 股审计资 ...

Meeting Overview - The 10th meeting of the 11th Supervisory Board of Beihai Guofa Chuanshan Biological Co., Ltd. was held on July 31, 2025, with all three supervisors participating in the voting [2][5] - The meeting was legally convened and chaired by Mr. Lü Qiujun [2] Audit Institution Appointment - The Supervisory Board approved the proposal to appoint Shanghai Shuhui Accounting Firm (Special General Partnership) as the special audit institution for the company's 2025 A-share issuance to specific targets [3][8] - The appointment does not require submission to the shareholders' meeting for approval [4] Audit Institution Details - Shanghai Shuhui Accounting Firm was established in January 1981 and has undergone several transformations, with its current form established in December 2013 [8] - The firm has provided audit services to 72 listed companies in 2024, with a total audit revenue of 0.81 billion yuan [9] - The firm has a total revenue of 0.683 billion yuan in 2024, with 0.204 billion yuan from securities business [9][10] Voting Results - The proposal received unanimous support from the Supervisory Board, with 3 votes in favor and no opposition or abstentions, representing 100% of the valid voting rights [5] Board Meeting Overview - The 17th meeting of the 11th Board of Directors was also held on July 31, 2025, with all 9 directors participating [21] - The Board approved the proposal to appoint the same audit institution for the 2025 A-share issuance, with a unanimous vote of 9 in favor [32][33] Financing Guarantee - The company agreed to provide a guarantee for its wholly-owned subsidiary, Beihai Guofa Pharmaceutical Co., Ltd., for a loan of 20 million yuan from China Postal Savings Bank [29][34] - The loan term is set for 3 years, and the company will not charge any guarantee fees [34][41] - The total amount of external guarantees before this loan was 0 yuan, and the new guarantee represents 2.58% of the company's audited net assets [44]

证券代码：300396 证券简称：迪瑞医疗 公告编号：2025-028 迪瑞医疗科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 迪瑞医疗科技股份有限公司（以下简称"公司"）于 2025 年 7 月 21 日召开 的第六届董事会第二次临时会议和第六届监事会第二次临时会议，审议通过了 《关于续聘 2025 年度审计机构的议案》，公司拟聘任大信会计师事务所（特殊 普通合伙）（以下简称"大信所"）为公司 2025 年度财务报告及内部控制的审 计机构，聘期为一年。2025 年度审计费用由董事会提请股东大会授权公司管理 层根据具体审计要求和审计范围与大信所协商确定，本事项需提交公司股东大会 审议批准。现将相关情况公告如下： 一、拟续聘会计师事务所事项的情况说明 大信会计师事务所具备会计师事务所执业证书和证券、期货相关业务许可证， 该公司在执业过程中坚持独立审计原则，能按时为公司出具各项专业报告，报告 内容客观、公正，表现了良好的职业操守和业务素质。综合考虑该所的审计质量 与服务水平情况，拟续聘大信会计师事务所作为公司 2025 年度审计机构，负责 公司 ...

Transaction Overview - The company plans to acquire the Silicon Valley SOHO-2 building project located in Changping District, Beijing, for a consideration of RMB 215 million [2][3] - The transaction does not constitute a related party transaction or a major asset restructuring as defined by the relevant regulations [2] - The acquisition was approved unanimously by the company's board of directors during a temporary meeting held on May 15, 2025, and does not require shareholder approval [3][30] Transaction Details - The acquisition involves purchasing the property from Beijing Boxing Zhongye Real Estate Development Co., Ltd., with a total area of 21,759 square meters, resulting in a price of RMB 9,880 per square meter [3][9] - The total estimated cost for the project is RMB 283.49 million, which includes the acquisition price, deed tax, and renovation costs [7] - The property is currently in a vacant state and consists of 415 units, primarily in a rough condition [5][10] Asset Valuation - An appraisal conducted by Beijing Kangzheng Hongji Real Estate Appraisal Co., Ltd. valued the property at RMB 331.13 million, translating to RMB 15,218 per square meter as of March 31, 2025 [8] Impact on the Company - This acquisition is expected to enhance the company's business scale, expand its operational footprint, and strengthen its market development capabilities, aligning with the company's future strategic goals and benefiting all shareholders [10]

Group 1 - The company plans to authorize its management to dispose of certain trading financial assets to maximize investment returns and protect shareholder interests [1] - The company acknowledges the inability to predict the specific impact of asset disposal on its performance due to market volatility [1] - The company will fulfill its information disclosure obligations based on the progress of asset disposal [1] Group 2 - Jiangsu Huaxi Village Co., Ltd. intends to reappoint Zhongxinghua Accounting Firm for the 2025 financial statement and internal control audit services, pending approval at the 2024 annual shareholders' meeting [3][4] - The audit fee for the 2025 fiscal year is set at 920,000 yuan, with no change from the previous year [13] - Zhongxinghua has a strong track record, with 1,052 registered accountants and a total revenue of approximately 203.34 million yuan for 2024 [4][6] Group 3 - The company held its ninth board meeting on April 28, 2025, where several key reports and proposals were approved, including the 2024 annual report and profit distribution plan [40][46] - The board's decisions will be submitted for approval at the upcoming shareholders' meeting scheduled for May 23, 2025 [83] - The company is also set to hold a performance briefing on May 9, 2025, to engage with investors and address their concerns [100][101]